Table 2

Associations between chromosomal or gene alterations, baseline characteristics, and treatment response

ParameterAgeBinet C vs A/BUnmut. IGHVZAP70 ≥20%CD38 ≥30%β2M >3.5 mg/LDel(11q)*Del(13q)*Del(17p)*Tri(12)*Chromosomal translocationsComplex karyotypesNonresponse to therapy
ATMmut ∅ ∅ .002↑ ∅ ∅ ∅ <.001↑ ∅ ∅ .045 .014↑ ∅ ∅ 
BIRC3mut .044 .048 ∅ ∅ ∅ ∅ (.070)↑ ∅ ∅ <.001↑ ∅ ∅ ∅ 
BRAFmut ∅ ∅ ∅ ∅ ∅ ∅ .030↑ ∅ ∅ ∅ ∅ ∅ ∅ 
CHD2mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
DDX3Xmut ∅ ∅ ∅ (.079)↑ ∅ (.069)↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
FAT1mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
FBXW7mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ (.098) ∅ .017↑ ∅ .025↑ ∅ 
KRASmut ∅ ∅ .014↑ .021↑ .005↑ ∅ ∅ (.098) ∅ ∅ (.058) ∅ .015↑ 
MYD88mut (.066) ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
NFKBIEmut ∅ ∅ ∅ ∅ ∅ ∅ .013↑ (.057)↑ ∅ ∅ ∅ ∅ ∅ 
NOTCH1mut (.057)↑ ∅ <.001↑ <.001↑ .006↑ .025↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
PIK3CGmut (.097)↑ (.067) ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
POT1mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ .039 ∅ (.074) ∅ 
SAMHD1mut ∅ ∅ ∅ (.086)↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
SF3B1mut ∅ ∅ ∅ .024↑ .009↑ ∅ ∅ (.088) ∅ ∅ .037 ∅ ∅ 
TP53mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ <.001↑ .012 (.072)↑ .011↑ .001↑ 
XPO1mut .040 ∅ .030↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
Chromosomal translocations ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ .002↑ ∅ NA <.001↑ ∅ 
Complex karyotypes ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ <.001↑ ∅ <.001↑ NA ∅ 
Nonresponse to therapy ∅ ∅ .007↑ ∅ ∅ ∅ ∅ ∅ .004↑ ∅ ∅ ∅ NA 
ParameterAgeBinet C vs A/BUnmut. IGHVZAP70 ≥20%CD38 ≥30%β2M >3.5 mg/LDel(11q)*Del(13q)*Del(17p)*Tri(12)*Chromosomal translocationsComplex karyotypesNonresponse to therapy
ATMmut ∅ ∅ .002↑ ∅ ∅ ∅ <.001↑ ∅ ∅ .045 .014↑ ∅ ∅ 
BIRC3mut .044 .048 ∅ ∅ ∅ ∅ (.070)↑ ∅ ∅ <.001↑ ∅ ∅ ∅ 
BRAFmut ∅ ∅ ∅ ∅ ∅ ∅ .030↑ ∅ ∅ ∅ ∅ ∅ ∅ 
CHD2mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
DDX3Xmut ∅ ∅ ∅ (.079)↑ ∅ (.069)↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
FAT1mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
FBXW7mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ (.098) ∅ .017↑ ∅ .025↑ ∅ 
KRASmut ∅ ∅ .014↑ .021↑ .005↑ ∅ ∅ (.098) ∅ ∅ (.058) ∅ .015↑ 
MYD88mut (.066) ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
NFKBIEmut ∅ ∅ ∅ ∅ ∅ ∅ .013↑ (.057)↑ ∅ ∅ ∅ ∅ ∅ 
NOTCH1mut (.057)↑ ∅ <.001↑ <.001↑ .006↑ .025↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
PIK3CGmut (.097)↑ (.067) ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
POT1mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ .039 ∅ (.074) ∅ 
SAMHD1mut ∅ ∅ ∅ (.086)↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
SF3B1mut ∅ ∅ ∅ .024↑ .009↑ ∅ ∅ (.088) ∅ ∅ .037 ∅ ∅ 
TP53mut ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ <.001↑ .012 (.072)↑ .011↑ .001↑ 
XPO1mut .040 ∅ .030↑ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ 
Chromosomal translocations ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ .002↑ ∅ NA <.001↑ ∅ 
Complex karyotypes ∅ ∅ ∅ ∅ ∅ ∅ ∅ ∅ <.001↑ ∅ <.001↑ NA ∅ 
Nonresponse to therapy ∅ ∅ .007↑ ∅ ∅ ∅ ∅ ∅ .004↑ ∅ ∅ ∅ NA 

Serum TK levels >10 U/L were not significantly associated with any mutation or chromosomal translocations/complex karyotypes and are therefore not included in this overview.

Arrows, direction of the association, eg, BIRC3 mutations are decreased in patients with higher median age; mut, mutation; NA, not applicable; ∅, absence of a statistically significant association (P < .05) or trend (P < .10; in parentheses) per χ2, Fisher’s exact test, or logistic regression (for nonresponse).

*

Detected by FISH.

Close Modal

or Create an Account

Close Modal
Close Modal